BioLife Solutions Inc (BLFS): Balans kapitallashuviga qarzlar

BioLife Solutions Inc (BLFS) tovar belgisi

BioLife Solutions, Inc. (BLFS) hujayralarni saqlashning ilg'or usullarini ishlab chiqishda yetakchilik qilmoqda hamda ilmiy tadqiqotlar va bulutli xizmatlarga katta resurslar investitsiya qilmoqda. Butun dunyo bo'ylab klinik sinovlarning ko'payishi mijozlar bazasini kengaytirmoqda, 0.04 ko'rsatkichi esa ushbu dinamikani tasdiqlaydi. Ushbu narxlar grafigi kompaniyaning bozordagi mavqeini namoyish etadi. Shu bilan birga, qurilmalar ishlab chiqarish robotlar va vizual tekshiruv tizimlari yordamida avtomatlashtirilgan, ammo yangi mahsulotlarni ishlab chiqish olimlarning mas'uliyatida qolmoqda.

BLFS - BioLife Solutions, Inc. Sof aktivlarga qarzlar 04.07.2022 - 18.10.2026 oraligʻida

BioLife Solutions Inc (BLFS) kompaniyasi koʻrsatkichlari kesimi va tahlili

BioLife Solutions, Inc. (BLFS) kompaniyasining indikatorlari:
Aksiya narxi BioLife Solutions, Inc.|BLFS - Tahlilchilar konsensus prognozi|Bozor kapitallashuvi BioLife|BLFS - Kompaniyaning to‘liq qiymati|Bitta aksiya hisobiga balans qiymati BioLife Solutions|BLFS - Biznesning balans bahosi|Bozor qiymatining balans qiymatiga nisbati biolifesolutions.com|BLFS - Kompaniya aktivlari|Qarzning xususiy kapitalga nisbati BioLife Solutions, Inc.|BLFS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati BioLife Corp|BLFS - Kompaniyaning umumiy qarz majburiyatlari|Balans kapitallashuviga qarzlar BioLife
Kompaniyaning fundamental tahlili:BioLife Solutions, Inc.
BioLife Solutions Inc original mahsuloti

Ushbu ko'rsatkich qarz kapitalining aksiyadorlik kapitaliga nisbatini o'lchab, biznesning moliyaviy barqarorligi va qarz yuklamasi darajasini belgilaydi. Qarz mablag'larining kitob kapitalizatsiyasiga nisbatini tahlil qilish orqali investorlar BioLife Solutions, Inc. (BLFS) kompaniyasining haddan tashqari yuqori kredit yuklamalarisiz avtomatlashtirilgan kriokonservatsiya tizimlari ishlab chiqishini moliyalashtirish qobiliyatini baholaydilar, bu esa hujayralar terapiyasi sohasidagi yuqori texnologik yechimlarni kengaytirish uchun juda muhimdir.

BioLife Solutions, Inc. raqobatchilari

Balans kapitallashuviga qarzlar TEM (Tempus AI Inc)|Balans kapitallashuviga qarzlar qiagen.com QGEN|IONS - Balans kapitallashuviga qarzlar|RGEN - Qarzning balans kapitallashuviga nisbati|Avidity - Balans kapitallashuviga qarzlar|CRSP (CRISPR) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati WGS (GeneDx Holdings Corp.)|Balans qiymatiga qarzlar RARE|Qarzning balans kapitallashuviga nisbati Beam Therapeutics (BEAM)|Qarzning balans kapitallashuviga nisbati Sarepta Therapeutics (SRPT)|Balans kapitallashuviga qarzlar TWST|Sof aktivlarga qarzlar 10x TXG|Balans kapitallashuviga qarzlar Intellia Therapeutics|STOK - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar WVE|Balans qiymatiga qarzlar Maze Therapeutics, Inc.|SION - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati PRME|TSHA (Taysha Gene Therapies) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar QURE (uniqure.com)|MGTX: Qarzning balans kapitallashuviga nisbati|REGENXBIO Inc - Balans qiymatiga qarzlar|SLDB - Qarzning balans kapitallashuviga nisbati|Ocugen Pharma (OCGN) - Qarzning balans kapitallashuviga nisbati|PACB: Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar benitec.com|Design Therapeutics, Inc. (DSGN) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati Rocket Pharma|FDMT (4D Molecular Therapeutics Inc) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar LXEO (lexeotx.com)|KRRO: Qarzning balans kapitallashuviga nisbati|editasmedicine.com - Balans qiymatiga qarzlar|Silence Therapeutics plc (SLN) - Qarzning balans kapitallashuviga nisbati|PRQR: Qarzning balans qiymatiga nisbati|codexis.com - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Sangamo BioSciences|NAUT - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati metagenomi.co|DTIL (Precision BioSciences, Inc.) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar GBIO (generationbio.com)|BOLD - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Exicure Inc. XCUR|IMNN: Balans kapitallashuviga qarzlar|Phio Pharmaceuticals (PHIO) - Qarzning balans qiymatiga nisbati|mustangbio.com - Qarzning balans qiymatiga nisbati|TransCode Therapeutics, Inc. (RNAZ) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar Bionano Genomics Inc.|Qarzning balans kapitallashuviga nisbati APDN|Qarzning balans kapitallashuviga nisbati bluebird bio, Inc. (BLUE)|Qarzning balans kapitallashuviga nisbati immunoprecise.com (IPA)|Omega Therapeutics, Inc. (OMGA) - Balans kapitallashuviga qarzlar|Singular Genomics Systems, Inc. - Qarzlarning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati RGLS (Regulus Therapeutics Inc)|SYRS - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar Telesis Bio, Inc.|TCON (traconpharma.com) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Unity Biotechnology, Inc. (UBX)